Propranolol Oral solution (Pierre Fabre)

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NamePropranolol Oral solution (Pierre Fabre)
Drug Alias NamePropaneroHemangeolHemangiolM7030M703101 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsHemangioma
Global Approved IndicationsHemangioma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/03/14
Country/TerritoryCzechiaCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUniversity of BordeauxPierre Fabre Medicament SAS
China Registration ClassN/A

Develop Information

Active CompaniesPierre Fabre GroupMaruho Co Ltd
Inactive CompaniesPierre Fabre Dermatology
Active IndicationsHemangioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A